IMC Chicago’s Agilon Health AGL Stock Holding History

IMC Chicago’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,235	Closed	-$316K	–	3114
2024 Q3	$514K	Buy	+5,235	New	+$676K	﹤0.01%	2401

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

IMC Chicago's AGL Position: Q4 2024 in Review

IMC Chicago sold out of Agilon Health (AGL) in Q4 2024, closing a stake of 5,235 shares — an estimated $316K sold.

IMC Chicago first reported a position in AGL in Q3 2024 and held it in 1 quarter. The position peaked at $514K in Q3 2024. 184 funds tracked by Wall St. Rank hold AGL as of Q4 2024.

IMC Chicago reported no remaining Agilon Health position as of Q4 2024 after selling out during the quarter.
IMC Chicago sold 5,235 Agilon Health shares in Q4 2024, an estimated $316K.
IMC Chicago first reported a position in Agilon Health in Q3 2024 and held it in 1 quarter.
IMC Chicago's Agilon Health position peaked at $514K in Q3 2024.
184 funds tracked by Wall St. Rank held Agilon Health as of Q4 2024.

Based on IMC Chicago's 13F filing for Q4 2024, filed 27 Jan 2025.